World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 58 3495 3224 240 223 353 14490

Sandra Ciesek publications per year

The chart shows the history of publications by Sandra Ciesek between 2004 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Sandra Ciesek published across 22 years, from 2004 to 2025, averaging 18.1 papers a year. Output peaked at 59 publications in 2021. 39 of the 399 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 2004 to 2025. Vertical axis: number of publications, 0 to 59. Peak 59 publications in 2021. 2004: 3 publications 2005: 2 publications 2006: 9 publications 2007: 4 publications 2008: 8 publications 2009: 10 publications 2010: 12 publications 2011: 15 publications 2012: 9 publications 2013: 14 publications 2014: 10 publications 2015: 12 publications 2016: 14 publications 2017: 7 publications 2018: 11 publications 2019: 14 publications 2020: 57 publications 2021: 59 publications 2022: 56 publications 2023: 34 publications 2024: 20 publications 2025: 19 publications
2004 2025

399 publications in total across all disciplines

View publications per year as a table
Sandra Ciesek: publications per year, 2004 to 2025
Year Publications
2004 3
2005 2
2006 9
2007 4
2008 8
2009 10
2010 12
2011 15
2012 9
2013 14
2014 10
2015 12
2016 14
2017 7
2018 11
2019 14
2020 57
2021 59
2022 56
2023 34
2024 20
2025 19
Total 399
Download as CSV

Sandra Ciesek publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sandra Ciesek sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 352–361 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 353 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69 353
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Sandra Ciesek D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sandra Ciesek sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 58–59 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201 58
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Sandra Ciesek is affiliated with Goethe University Frankfurt in Germany and has a substantial body of research primarily in the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Hepatology, Molecular Biology, and Immunology. Their research portfolio reflects extensive publication and study on viral infections, including SARS-CoV-2 and COVID-19.

The scientist's recent publications highlight their involvement in identifying mechanisms of viral spread and possible therapeutic targets related to SARS-CoV-2. Key papers include:

  • "Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity" (2020, Nature)
  • "Proteomics of SARS-CoV-2-infected host cells reveals therapy targets" (2020, Nature)
  • "Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China" (2020, New England Journal of Medicine)
  • "Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risks" (2020, The Science of The Total Environment)
  • "Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies" (2021, bioRxiv - Cold Spring Harbor Laboratory)

The subjects covered in their work extend over various topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Animal Virus Infections Studies
  • COVID-19 epidemiological studies

Frequent coauthors collaborating with Sandra Ciesek include Denisa Bojková, Marek Widera, Jindřich Činátl, Sebastian Hoehl, and Holger F. Rabenau. These collaborations indicate active engagement within a broad network of infectious disease researchers.

Publication venues prominently featuring their work are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Hepatology
  • Journal of Clinical Virology
  • Journal of Medical Virology
  • Viruses

The scientist's research output reveals a concentrated effort on understanding viral pathogenesis, immune responses, and epidemiological characteristics, particularly in the context of the COVID-19 pandemic. Their work contributes to ongoing efforts in viral detection methods, clinical research, and identification of possible therapeutic interventions.

Best Publications

  • Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.

    Denisa Bojkova;Kevin Klann;Benjamin Koch;Marek Widera

  • Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.

    Donghyuk Shin;Donghyuk Shin;Rukmini Mukherjee;Diana Grewe;Denisa Bojkova

  • Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.

    Sebastian Hoehl;Holger Rabenau;Annemarie Berger;Marhild Kortenbusch

  • A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

    Johannes Haybaeck;Nicolas Zeller;Monika Julia Wolf;Achim Weber

  • Detection of SARS-CoV-2 in raw and treated wastewater in Germany – Suitability for COVID-19 surveillance and potential transmission risks

    Sandra Westhaus;Frank Andreas Weber;Sabrina Schiwy;Volker Linnemann

  • Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies

    Unknown

  • Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.

    Christoph Schultheiß;Lisa Paschold;Donjete Simnica;Malte Mohme

  • Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

    Unknown

  • The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.

    Sandra Ciesek;Thomas von Hahn;Che C. Colpitts;Luis M. Schang

  • Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

    Dorothea Bankwitz;Eike Steinmann;Julia Bitzegeio;Sandra Ciesek

  • Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.

    Kevin Klann;Denisa Bojkova;Georg Tascher;Sandra Ciesek;Sandra Ciesek

  • SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.

    Denisa Bojkova;Julian U G Wagner;Mariana Shumliakivska;Galip S Aslan

  • Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection

    Kerstin A. Stegmann;Kerstin A. Stegmann;Niklas K. Björkström;Heike Veber;Sandra Ciesek

  • The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

    Gerrit Gehring;Katrin Rohrmann;Nkacheh Atenchong;Eva Mittler

  • Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.

    Niko Kohmer;Sandra Westhaus;Cornelia Rühl;Sandra Ciesek

  • Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.

    Sandra Ciesek;Eike Steinmann;Heiner Wedemeyer;Michael P. Manns

  • The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro.

    Niko Kohmer;Tuna Toptan;Christiane Pallas;Onur Karaca

  • Clinical performance of different SARS-CoV-2 IgG antibody tests.

    Niko Kohmer;Sandra Westhaus;Cornelia Rühl;Sandra Ciesek

  • Lack of antiviral activity of darunavir against SARS-CoV-2.

    Sandra De Meyer;Denisa Bojkova;Jindrich Cinatl;Ellen Van Damme

  • Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces

    Juliane Doerrbecker;Martina Friesland;Sandra Ciesek;Thomas J. Erichsen

  • GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection

    Heiner Wedemeyer;Katrin Schöneweis;Pavel O. Bogomolov;Natalia Voronkova

  • How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides

    Sandra Ciesek;Martina Friesland;Jörg Steinmann;Britta Becker

Frequent Co-Authors

Eike Steinmann
Eike Steinmann Ruhr University Bochum
Thomas Pietschmann
Thomas Pietschmann Hannover Medical School
Jindrich Cinatl
Jindrich Cinatl Goethe University Frankfurt
Michael P. Manns
Michael P. Manns Hannover Medical School
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
Holger F. Rabenau
Holger F. Rabenau Goethe University Frankfurt
Annemarie Berger
Annemarie Berger Goethe University Frankfurt
Christoph Sarrazin
Christoph Sarrazin Goethe University Frankfurt
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Gerd Geisslinger
Gerd Geisslinger Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, including nursing and advanced practice roles. Many professionals enhance their expertise by pursuing specialized certifications such as acute care nurse practitioner certification, which equips them to handle complex patient care in hospital settings.

For those seeking to fast-track their nursing careers, enrolling in a nurse practitioner accelerated program offers a streamlined path to becoming a nurse practitioner. These programs are designed for individuals with prior healthcare experience or degrees, fostering a quicker transition into advanced practice roles.

Non-nurses interested in healthcare can also benefit from online nursing programs for non nurses. These programs provide foundational nursing education tailored for those starting fresh in the field, offering flexible online learning options to accommodate different schedules.

Understanding career potential is crucial. Resources detailing dnp salary transparency help candidates make informed decisions based on regional salary differences for Doctor of Nursing Practice graduates. This insight supports smart career planning within immunology-related healthcare roles.

Best Scientists Citing Sandra Ciesek

Trending Scientists

Recently Published Articles